Buruli ulcer

Buruli ulcer research

Tim Stinear
Overview of the proposed pathway for the production of mycolactones by Mycobacterium ulcerans.

Research priorities & news


Among the many potentially important areas of research on Buruli ulcer, six priority areas were selected by the research subgroup at the 5th WHO Advisory Group Meeting on Buruli Ulcer.
Read more

Buruli ulcer clinical trial

The ultimate goal is to search for an effective oral treatment to the current standard WHO-recommended therapy for all forms of Buruli ulcer, which includes injections of streptomycin.

Research consortia

Research network

The following institutions are involved in Buruli ulcer research activities:

Buruli in the news!

19 November 2015 | Geneva
New research shows the diagnostic potential of fluorescent thin layer chromatography to detect mycolactone in Buruli ulcer


12 November 2015 | Geneva
Despite limitations, clinical practice and observational data are allowing acquisition of knowledge - crucial to informing international guidance for Buruli ulcer disease management


30 September 2015 | Geneva
Rapid diagnosis of Buruli ulcer now possible at district-level health facilities


05 March 2015 | Geneva
Management of Buruli ulcer–HIV coinfection – Technical update
Ref: WHO/HTM/NTD/IDM/2015.01


10 facts on Buruli ulcer
Read the 10 facts


Laboratory confirmation
Guidance on sampling techniques for laboratory-confirmation of Mycobacterium ulcerans infection (Buruli ulcer disease)